US 9943594
Methods for the treatment of rheumatoid arthritis
granted A61KA61K2039/54A61K2039/545
Quick answer
US patent 9943594 (Methods for the treatment of rheumatoid arthritis) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/54, A61K2039/545, A61K31/42, A61K31/4706